Useful Videos for Cipla Pharmaceutical Company
News & News Articles on: Cipla Pharmaceutical Company
Ranbaxy, Cipla Stocks on Roller Coaster Ride [Source: Bloggingstocks.com]
The company inked an agreement with India’s pharmaceutical producer Cipla to market Cipla’s over-the-counter and prescription drugs in Russia and the Ukraine. “Marketing of Cipla’s portfolio in Russia began in the recently-ended second fiscal quarter; the …
[Click here to Read the Full Article/NEWS]
Indian Pharmaceutical Industry – looking beyond generics Available through Bharatbook [Source: Asian Age]
Further gains are likely in Dr Reddy, Lupin, Cipla, Dabur and HLL. Ahead of the FPO of SCI … Gutsy traders can attempt buying in Reliance Infra and Reliance Power. Plethico Pharmaceuticals Ltd is a an emerging healthcarecompany with strong emphasis on …
[Click here to Read the Full Article/NEWS]
Research and Markets: Examine India’s Pharmaceuticals Indsutry with this 2H10 Report as the US Remains [Source: MoneyControl.com]
A study of the SBI Mutual Funds portfolio for the month of October 2010 showed that in the pharmaceuticals sector, it purchased Cipla, Lupin … where it sold Tata Power Company, NTPC and Power Grid Corporation, while it bought NHPC.
[Click here to Read the Full Article/NEWS]
Cipla Q2 net declines 5%; no decision yet on African investment [Source: Economic Times]
Companies across various sectors, including pharmaceuticals, steel … Sun Pharma and Lupin have posted good performance on the back of a revival in US markets. Cipla’s performance was helped by good show in the domestic market. Going forward, Sun Pharma …
[Click here to Read the Full Article/NEWS]
Silk Road to India: HDFC (HDB) and Dr. Reddy’s (RDY) [Source: Sify]
Tata Consultancy Services (down 2.1%), ONGC (down 1.9%), Cipla (down 1.3%) and BHEL (down 1.1% … Ranbaxy Laboratories is down with a loss of 1.5% at Rs 594 despite the company reporting better-than-expected results. Ranbaxy, controlled by Japan’s Daiichi …
[Click here to Read the Full Article/NEWS]
Markets to remain volatile due to F&O settlement [Source: Economic Times]
The only losers were NTPC (-0.87%), Sterlite (-0.23%) and L&T (-0.19%). 3:10 pm: Bafna Pharmaceuticals Ltd has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Finasteride 5 MG tablets. On BSE, the company’s …
[Click here to Read the Full Article/NEWS]
Useful RSS Feeds related with Cipla Pharmaceutical Company
Useful eBooks & PDFs for Cipla Pharmaceutical Company
- chairmans speach.cdr – Cipla
- Seventy-First Annual General Meeting – Cipla
- chairmans speach 25-08-10.cdr – Cipla
- Economics 560 P. Conway CIPLA Ltd. And the Provision of Anti-AIDS …
- The Indian Pharmaceutical Market to 2011
- Stempeutics announces clinical trial outcome of India’s FIRST stem …
- Piramal Healthcare Limited Acquires “i-pill”, India’s No 1 …
- Merck, AIDS, and Africa
- Oseltamivir 75 mg (as phosphate) Capsules (Cipla Ltd.)
- ^4ì^ % 20 ^rat ÎWiï if WT Cipla hires 20 from SBS Tribune News …
- Exploration of parameters for brand promotion for next generation …
Useful Resources & Links:
- Cipla
- Cipla – Wikipedia, the free encyclopedia
- Cipla Ltd – Cipla India Profile – Cipla Pharmaceutical – Cipla …
- Cipla – History
- Cipla Pharmaceuticals‘ Yusuf Hamied: ‘I Am Not Against Patents …
- Cipla: Information from Answers.com
- Cipla Ltd – Mumbai India – Company Snapshot – AlacraStore.com
- Cipla Medpro Pharmaceuticals, South Africa – Pharmaceutical Technology
- Indian Generic Drug Company Cipla Receives FDA Approval For U.S …
- Cipla Pharmacuetical – Generic Pharmaceutical Manufacturer, API …
Recent Comments